New Atypical Antipsychotic Approved

A new atypical antipsychotic drug, lurasidone (Latuda) has been approved to treat schizophrenia in adults. As with other drugs in this class, lurasidone isn't approved for older adults with dementia-related psychosis. Lurasidone has the same adverse effects profile as other atypical antipsychotics, including an increased risk of death, particularly from cerebrovascular causes.